Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00004580 · ClinicalTrials.gov registry record · Phase 1
A Study of ABT-378/Ritonavir Combination in HIV-Infected Patients Who Have Taken Protease Inhibitors
A Phase 1 study, sponsored by Abbott.
- Completed
- Registry status
- Phase 1
- Development phase
NCT00004580: Completed Phase 1 study, sponsored by Abbott.
NCT00004580 is a Phase 1 study that has completed, run by Abbott. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00004580, a Phase 1 study, has completed, sponsored by Abbott.
- COMPLETED
- Registry status
- Phase 1
- Development phase
Study Summary
The purpose of this study is to see if it is safe and effective to give ABT-378/ritonavir combination plus nevirapine plus two nucleoside transcriptase inhibitors to HIV-infected patients who previously have taken protease inhibitors. This study also examines how the body handles this combination of anti-HIV drugs.
Interventions
- DRUG Nevirapine
- DRUG Lopinavir/Ritonavir
Trial Details
| Field | Value |
|---|---|
| Phase | Phase 1 |
What the finished NCT00004580 record still lists
NCT00004580 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 2 interventions - of which Nevirapine is the first listed.
NCT00004580 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00004580 about?
NCT00004580 is a clinical study titled "A Study of ABT-378/Ritonavir Combination in HIV-Infected Patients Who Have Taken Protease Inhibitors". The purpose of this study is to see if it is safe and effective to give ABT-378/ritonavir combination plus nevirapine plus two nucleoside transcriptase inhibitors to HIV-infected patients who previously have taken protease inhibitors. This study also examines how the body handles this combination of...
What is the current status of trial NCT00004580?
This trial is currently completed. It is a Phase 1 study.
What interventions are being tested in trial NCT00004580?
The interventions under investigation include: Nevirapine (DRUG), Lopinavir/Ritonavir (DRUG).
Who is sponsoring clinical trial NCT00004580?
This trial is sponsored by Abbott, which has 181 total clinical trials registered on ClinicalTrials.gov.